JIE MENG | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. JIE MENG | Neuroscience | Best Researcher AwardĀ šŸ†

Assistant Professor at Sichuan University, China.

Dr. Jie Meng is an Assistant Professor at Sichuan University, China. With expertise in [specific field, e.g., molecular biology, environmental science, engineering], Dr. Meng has contributed significantly to both research and teaching. His work focuses onDr. Meng has published [number] papers in reputed journals and actively participates in academic conferences. He is committed to advancing knowledge in his field while fostering a collaborative learning environment for students at Sichuan University.

Profile

ORCID

Scopus

Education šŸŽ“:

Jie Meng holds a Ph.D. in Neuroscience from Kyushu University, Japan, completed in 2019. This advanced education provided a solid foundation in understanding the intricate mechanisms underlying neurodegenerative diseases.

Work Experience šŸ’¼:

Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimerā€™s disease and Parkinsonā€™s disease.

Awards and Honors

Jie Mengā€™s exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.

Research Interests:

Jie Mengā€™s research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinsonā€™s disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinsonā€™s disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.

šŸ“š PublicationĀ 

  • Testing cognitive normal for Alzheimer’s disease prediction
    Citations: 0
    Year: 2025
    Authors: Meng, J., Lei, P.
    Journal: Journal of Neurochemistry

 

  • Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Citations: 2
    Year: 2024
    Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
    Journal: Genes and Diseases

 

 

  • How brain ā€˜cleanersā€™ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
    Citations: 12
    Year: 2024
    Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
    Journal: GLIA

 

  • Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2Ī±/ACSL4 signaling pathway
    Citations: 5
    Year: 2024
    Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
    Journal: Translational Oncology

 

 

  • Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Citations: 3
    Year: 2023
    Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
    Journal: MedComm

 

  • The Dual Nature of Microglia in Alzheimerā€™s Disease: A Microglia-Neuron Crosstalk Perspective
    Citations: 8
    Year: 2023
    Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
    Journal: Neuroscientist

 

  • Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
    Citations: 8
    Year: 2023
    Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
    Journal: Zoological Research

 

  • Microglial cathepsin E plays a role in neuroinflammation and amyloid Ī² production in Alzheimerā€™s disease
    Citations: 14
    Year: 2022
    Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
    Journal: Aging Cell

 

  • Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
    Citations: 6
    Year: 2022
    Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
    Journal: Molecular Neurobiology

 

  • Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
    Citations: 28
    Year: 2020
    Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
    Journal: Neurobiology of Aging

 

ConclusionĀ 

In conclusion, to fully assess Dr. Jie Mengā€™s suitability for the Best Researcher Award, one would need to gather detailed information on their research outputs, contributions to the field, collaborations, and overall recognition. If their work aligns with the criteria outlined above, Dr. Meng could very well be a strong contender for the award. Additionally, providing more details on their specific research achievements would allow for a more tailored evaluation and clearer recommendations for areas where they could continue to excel.

 

Harender Kumar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Harender Kumar | Neuroscience | Best Researcher AwardĀ šŸ†

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education šŸŽ“:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience šŸ’¼:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumarā€™s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harenderā€™s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

šŸ“š PublicationsĀ 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

ConclusionĀ 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Hristina Čolović | Neuroscience | Robotics Integration Award

Posted on by sciencefather

Prof. Dr. Hristina Čolović | Neuroscience | Robotics Integration Award

spec.Physical Medicine and Rehabilitation at University of Nis, Faculty of Medicine, Serbia 2 Physical Medicine and Rehabilitation Clinic, Clinical Center of Nis, Serbia, SerbiašŸŽ“

Dr. Hristina Čolović is an accomplished Physiatrist specializing in physical medicine and rehabilitation, with a particular focus on pediatric rehabilitation and the use of botulinum toxin in treating spasticity in children with cerebral palsy. With a robust academic background, including a PhD in Physical Medicine and Rehabilitation, she has made significant contributions to the field, especially in robotic neurorehabilitation after pediatric stroke. She is actively involved in clinical practice, research, and teaching, and has a record of publications in notable scientific journals.

 

ProfileĀ 

Scopus

Education šŸŽ“:

Dr. Hristina Čolović completed her undergraduate studies at the Faculty of Medicine, University of Nis, Serbia, in 1992, with a distinguished average grade of 9.06. She pursued specialization in Physical Medicine and Rehabilitation at the same institution, receiving excellent grades (5/5) in 1998. Dr. Čolović furthered her expertise with a subspecialization in Pediatric Rehabilitation from the Faculty of Medicine, University of Belgrade, in 2007, earning another top grade. She completed her Ph.D. in 2012, focusing on the effects of Botulinum toxin type A in the habilitation of children with cerebral palsy. Her academic foundation and continuing education have provided a solid basis for her leadership in both clinical practice and research. Dr. Čolović’s ongoing commitment to academic development is reflected in her teaching roles, where she lectures on physical medicine, pediatric rehabilitation, and neurorehabilitation at the University of Nis and other institutions.

Work Experience šŸ’¼:

Dr. Hristina Čolović has an extensive career in physical medicine and rehabilitation, spanning over 25 years. She has been a full-time faculty member at the Clinic for Physical Medicine, Rehabilitation, and Prosthetics in Nis, Serbia, since 1995. Starting in 2008, she pioneered the use of botulinum toxin type A in treating children with cerebral palsy, a therapy she has continued to develop and refine. In addition to her clinical practice, Dr. Čolović has served as a professor at the Faculty of Medicine, University of Nis, specializing in physical medicine and rehabilitation, where she trains future healthcare professionals. She has also been a lecturer in pediatric rehabilitation at the College of Health Sciences in Ćupria, Serbia. Dr. Čolovićā€™s career also includes significant involvement in continuing medical education, where she has lectured on topics such as botulinum toxin application and rehabilitation of foot deformities in children.

Awards and HonorsšŸ†

Dr. Hristina Čolović has received numerous awards and honors throughout her distinguished career. She has been recognized for her excellence in both clinical practice and research in the field of physical medicine and rehabilitation. Her contributions to the treatment of children with cerebral palsy using botulinum toxin type A have been particularly noteworthy. In addition to her clinical work, she has earned accolades for her leadership in education and continuous medical training. Dr. Čolovićā€™s research and teaching have been instrumental in advancing pediatric rehabilitation in Serbia and beyond. She has been honored by various medical institutions, including the Serbian Medical Society and the Serbian Medical Chamber. Her role as an invited speaker and lecturer at numerous national and international conferences further highlights her esteemed standing within the medical community. Dr. Čolović’s continued dedication to improving healthcare outcomes, particularly for children with physical disabilities, makes her a respected figure in the field.

Research Focus šŸ”¬:

Dr. Hristina Čolovićā€™s research focuses primarily on pediatric rehabilitation, with a particular emphasis on cerebral palsy and musculoskeletal disorders in children. Her pioneering work on the use of botulinum toxin type A for managing spasticity in children with cerebral palsy has had a significant impact on the field, improving functional outcomes for these children. She is also interested in exploring rehabilitation strategies for other pediatric conditions, such as congenital foot deformities and hip dysplasia. Dr. Čolovićā€™s work involves both clinical applications and functional assessments, aiming to enhance the overall quality of life for children with physical disabilities. Her research contributions include studies on motor activity in premature infants and the effects of rehabilitation interventions on neurological outcomes. Through her research, Dr. Čolović seeks to bridge the gap between innovative treatments and their practical applications in improving the health and mobility of pediatric patients, particularly those with spasticity and developmental disabilities.

šŸ“š Publications

    • A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke
      Authors: Čolović, H., Zlatanović, D., Zivković, V., Jovanović, K., Nikolić, D.
      Citations: 0
      Year: 2024
    • Can pre-treatment dysfunctional voiding and incontinence scoring system score predict treatment outcome in children with dysfunctional voiding ā€“ a randomized trial
      Authors: Živković, V.D., Čolović, H., Zlatanović, D., Vlajković, M.
      Citations: 0
      Year: 2023
    • The importance of assessing general motor activity in premature infants for predicting neurological outcomes
      Authors: Zlatanović, D., Čolović, H., Živković, V., Vučić, J., ToÅ”ić, T.
      Citations: 1
      Year: 2022
    • Factors associated with poor self-reported function and quality of life in patients with end-stage knee or hip osteoarthritis immediately prior to total joint arthroplasty
      Authors: Kocić, M., Milenković, M., Nikolić, D., Čolović, H., Stojanović, Z.
      Citations: 4
      Year: 2021
    • Endometrial immunocompetent cells in proliferative and secretory phase of normal menstrual cycle
      Authors: JanoÅ”evic, D.R., JanoÅ”evic, D.R., Trandafilović, M., Dinic, S.P.-T., Dinic, S.P.-T.
      Citations: 12
      Year: 2020
    • Upper limb robotic neurorehabilitation after pediatric stroke
      Authors: Čolović, H., Dimitrijević, L., Đurić, V., Janković, S.
      Citations: 3
      Year: 2020
    • Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?
      Authors: Čolović, H., Dimitrijevic, L., Stanković, I., Radović-JanoÅ”ević, D., Zlatanović, D.
      Citations: 1
      Year: 2020
    • The Role of Early Habilitation in Infants with Congenital Brachial Palsy
      Authors: Živković, V.D., Stanković, I., Dimitrijević, L., Spalević, M., Savić, N.
      Citations: 1
      Year: 2018
    • The effect of physical therapy in the treatment of patients with cervical dystonia with or without concomitant use of botulinum toxin
      Authors: Stanković, I., Čolović, H., Živković, V., Živković, D., Stanković, T.
      Citations: 2
      Year: 2018
    • Chemoinformatic investigation of antibiotic antagonism: The interference of thymus glabrescens essential oil components with the action of streptomycin
      Authors: Ilić, B.S., Miladinović, D.L., Kocić, B.D., Čolović, H., Nikolić, D.M.
      Citations: 3
      Year: 2017

 

ConclusionĀ 

Dr. Hristina Čolovićā€™s profile indicates strong potential for the Robotics Integration Award. Her expertise in physical medicine and rehabilitation, combined with her research into robotic neurorehabilitation, makes her an excellent candidate for recognition. With further development in broader robotics applications and enhanced collaboration with engineers, Dr. Čolović could lead the way in advancing robotic integration into rehabilitation practices, positively impacting patient care across various domains.

 

 

Prof. Dr. binli | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Dr. binli | Neuroscience | Best Researcher Award šŸ†

Lecturer (University Professor) at yangzhou university,ChinašŸŽ“

The nominee, a PhD holder in Architecture since 2016, has demonstrated excellence in research, education, and practical applications in architecture and sustainability. His dual focus on comfort and accessibility, alongside nature-based solutions for climate resilience, addresses critical contemporary issues. His notable contributions, backed by research grants and real-world projects, underscore his commitment to advancing sustainable architecture.

 

Professional ProfileĀ 

šŸŽ“ Education

Bin Li earned his Ph.D. in Neuroscience from Nanjing Agricultural University, where his master’s thesis was recognized as an excellent thesis. His educational background laid a strong foundation for his expertise in neuroimmunology and endothelial cell research. šŸŽ“šŸ†

šŸ¢ Work Experience

As a university-appointed professor, Bin has made significant contributions to the field of Neuroscience. His work focuses on the mechanisms of mRNA methylation in endothelial cells and their role in recovery after ischemic stroke, enhancing our understanding of neurovascular repair processes. šŸ§ šŸ„

šŸ§¬ Skills

  • Bin possesses advanced research skills in molecular biology and neuroimmunology, with a strong capability in conducting complex experiments and data analysis. His ability to communicate complex scientific concepts effectively enhances his teaching and mentorship roles. šŸ§ŖšŸ“Š

Awards and Honors šŸ†

He has received numerous accolades, including the “Lv Yang Jin Feng” Outstanding Doctor award and recognition for an outstanding paper at the 19th National Academic Exchange Meeting on Neuropsychopharmacology in 2021. šŸ„‡šŸŽ–ļø

MembershipsšŸ“œĀ 

Bin is an active member of professional organizations, including the Neuroimmunology Branch of the Jiangsu Society of Immunology and the Basic Veterinary Branch of the Jiangsu Animal Husbandry and Veterinary Association, which facilitate collaboration and knowledge exchange in his field. šŸ¤šŸŒ

šŸ“š Teaching Experience

In his role as a lecturer, Bin is dedicated to educating the next generation of scientists, fostering a stimulating learning environment, and guiding students through advanced concepts in Neuroscience and immunology. šŸ“–šŸ‘Øā€šŸ«

šŸ”¬ Research Focus

His current research investigates glial cell-to-neuron and endothelial cell inter-communication during post-ischemic injury, aiming to uncover novel therapeutic strategies for brain recovery. With a total of 12 published papers and significant citations, his research is influential in the field. šŸ”šŸ§¬

ConclusionĀ 

In conclusion, Dr. Bin Li exemplifies the qualities of a leading researcher deserving of the Best Researcher Award. His innovative research, impressive publication record, and active engagement in the scientific community highlight his significant contributions to neuroscience. Addressing the areas for improvement could further amplify his impact, making him a valuable asset to both academia and society. Dr. Li’s commitment to advancing knowledge in neurovascular repair positions him as an outstanding candidate for this prestigious recognition.

šŸ“š PublilcationĀ 

  • EHR coding with hybrid attention and features propagation on disease knowledge graph
    • Year: 2024
    • Journal: Artificial Intelligence in Medicine
  • DAJLENet: A neural network based on dual attention and joint learning for explainable heart failure adverse event prediction
    • Year: 2024
    • Journal: Computers and Electrical Engineering
  • Application programming interface recommendation for smart contract using deep learning from augmented code representation
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process
  • Extraction of Corn Plant Phenotypic Parameters with Keypoint Detection and Stereo Images
    • Year: 2024
    • Journal: Agronomy
  • Ponzi Scheme Detection in Smart Contract via Transaction Semantic Representation Learning
    • Year: 2024
    • Journal: IEEE Transactions on Reliability
  • Normalization of kinship relations to enrich family network analysis: case study on China biographical database
    • Year: 2024
    • Journal: Digital Scholarship in the Humanities
  • Fine-grained smart contract vulnerability detection by heterogeneous code feature learning and automated dataset construction
    • Year: 2024
    • Journal: Journal of Systems and Software
  • Neurodynamics for Equality-Constrained Time-Variant Nonlinear Optimization Using Discretization
    • Year: 2024
    • Journal: IEEE Transactions on Industrial Informatics
  • Automatic software vulnerability classification by extracting vulnerability triggers
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process

 

 

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at Ā Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

ScopusĀ 

Education šŸŽ“

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience šŸ’¼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills šŸ§ 

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors šŸ†

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimerā€™s Association in Chicago (1998).

Membership šŸ¤

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience šŸ“š

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus šŸ”¬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving Ī²-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimerā€™s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimerā€™s Disease-Related Genesā€”A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimerā€™s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimerā€™s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Bloodā€“Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimerā€™s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr NISHI PATEL | Neuroscience | Best Researcher AwardĀ Ā  šŸ†

Research Scholar at Bhagwan Mahavir University, Surat , IndiašŸŽ“

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease šŸ§ . With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinsonā€™s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional ProfileĀ 

  • Google ScholarĀ 

Education šŸŽ“

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience šŸ¢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors šŸ†

While specific awards are not mentioned, Dr. Patelā€™sĀ numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus šŸ”

Dr. Patelā€™s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinsonā€™s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications :Ā 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum ā€“ An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinsonā€™s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award šŸ†

Division of Diabetes and Nutrition at RARiS, Tohoku University,Ā Japan
šŸŽ“

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional ProfileĀ 

šŸ“š Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

šŸŽ–ļø Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

šŸŒ Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofengā€™s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications :Ā 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAwardĀ  šŸ†

Principal Scientist of Cognitive Health atĀ DSM-Firmenich, RD Innovation
SwitzerlandšŸŽ“

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional ProfileĀ 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

SkillsĀ 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

Ā MembershipĀ 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications :Ā 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    šŸ§  International Journal of Molecular Sciences ā€“ 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    šŸ§¬ Cell ā€“ 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    šŸ”¬ The Journal of Neuroscience ā€“ 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    šŸ§© Biological Psychiatry ā€“ 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    šŸ§  Neuron ā€“ 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    šŸ§  Current Opinion in Neurobiology ā€“ 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    šŸ Neurobiology of Learning and Memory ā€“ 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    šŸ§  Learning & Memory (Cold Spring Harbor, N.Y.) ā€“ 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    šŸ§  The Journal of Neuroscience ā€“ 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    šŸ’Š The American Journal of Gastroenterology ā€“ 2011
    DOI: 10.1038/ajg.2011.179

Dr Andreu Massot TarrĆŗs | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Andreu Massot TarrĆŗs | Neuroscience | Best Researcher Award šŸ†

Neurologist at Hospital Universitari MĆŗtua Terrassa, SpainšŸŽ“

Andreu Massot TarrĆŗs, MD, PhD, is a highly accomplished neurologist and epileptologist with over 20 years of experience. He earned his Medical Doctorate from the Universitat AutĆ²noma de Barcelona in 2003 and later completed a PhD Cum Laude in Medicine, focusing on intracranial atherostenosis. He has held senior neurology positions at prestigious hospitals in Spain, including Hospital Universitari Vall dā€™Hebron, JimĆ©nez DĆ­az Foundation, and Hospital Universitari MĆŗtua Terrassa, where he currently serves. Dr. Massot TarrĆŗs has specialized expertise in epilepsy, EEG, and cerebrovascular diseases and has completed advanced fellowships in Canada and the UK.

Professional ProfileĀ 

Education

Andreu Massot TarrĆŗs earned his Medical Doctorate in August 2003 from the Universitat AutĆ²noma de Barcelona. He went on to complete his Neurology specialization in May 2009 at the Hospital Universitari Vall dā€™Hebron, Barcelona. In June 2013, he was awarded a PhD Cum Laude in Medicine by the same university for his thesis on intracranial atherostenosis, supervised by Dr. Montaner Villalonga and Dr. Ɓlvarez-SabĆ­n. His commitment to epilepsy research led him to a Clinical and Research Fellowship in Epilepsy and EEG at Western University, Ontario, in 2014, followed by a Master in Epilepsy from the Universidad de Murcia in 2018, where he received an excellent qualification.

Ā Work Experience

Dr. Massot TarrĆŗs’s medical career has spanned several prestigious institutions. Starting as a clinical observer in London (2008), he then became a Senior Neurologist in Barcelona and Madrid, working in the Neurovascular Unit at Vall dā€™Hebron (2009-2010) and the Epilepsy Unit at the JimĆ©nez DĆ­az Foundation (2010-2011). Between 2011 and 2021, he took on various senior roles, including at Hospital del Mar and Hospital Universitario Gregorio MaraĆ±Ć³n, Madrid. Since September 2021, he has been a Senior Neurologist and Epileptologist at Hospital Universitari MĆŗtua Terrassa, where he continues to excel in treating neurological disorders, particularly epilepsy.

Ā SkillsĀ 

Dr. Massot TarrĆŗs is highly skilled in Electroencephalography (EEG) and Video-EEG monitoring. He has extensive experience in intraoperative electrocorticography, cortical stimulation mapping, and the Wada test. His expertise in cerebrovascular diseases and ultrasonography diagnostics has made him a leading lecturer at several top hospitals, including Vall dā€™Hebron, Hospital del Mar, and Hospital Gregorio MaraĆ±Ć³n.

Awards & Honors

He holds certifications in Electroencephalography from both the Canadian Society of Clinical Neurophysiology (2015) and the Spanish Society of Neurology (2016). He was also awarded a Cum Laude distinction for his doctoral work and has participated in advanced training like the NIH Stroke Scale Training by the National Stroke Association.

Ā MembershipĀ 

Dr. Massot TarrĆŗs is an active member of the Spanish Society of Neurology and has contributed significantly to clinical neurophysiology through his memberships in various international medical bodies.

Ā Teaching Experience

Dr. Massot TarrĆŗs has shared his knowledge extensively, offering lectures on epilepsy, neurovascular diseases, and ultrasonography techniques. He has taught at institutions like JimĆ©nez DĆ­az Foundation, Hospital del Mar, and Western University, where his work in EEG and cerebrovascular illness has helped shape the careers of future neurologists.

Ā Research Focus

His research primarily focuses on epilepsy and ischemic cerebrovascular diseases. His PhD thesis, which examined markers of recurrence in intracranial atherostenosis, highlights his dedication to improving diagnostics and treatment outcomes in neurology. He continues to contribute to research on epilepsy and cerebrovascular conditions, aiming to reduce the recurrence of ischemic events in patients.

 

šŸ“–Publications :Ā 

  • šŸ“„ “Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program”
    Author: Massot-TarrĆŗs, A.
    Journal: Epilepsia Open
    Year: 2023
    Volume: 8(3), pp. 918ā€“929
  • šŸ“Š “Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study”
    Author: Massot-TarrĆŗs, A.
    Journal: Data in Brief
    Year: 2022
    Volume: 45, 108568
  • šŸ§  “Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy”
    Author: Massot-TarrĆŗs, A.
    Journal: Frontiers in Neurology
    Year: 2022
    Volume: 13, 884730
  • šŸ’Š “Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice”
    Co-author: Massot-TarrĆŗs, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108836
  • šŸ“ˆ “Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study”
    Author: Massot-TarrĆŗs, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108780
  • šŸ§© “Cortical myoclonus associated with coeliac disease showing a characteristic EEG pattern: A case report”
    Author: Massot-TarrĆŗs, A.
    Journal: Seizure
    Year: 2022
    Volume: 95, pp. 81ā€“83
  • šŸš‘ “Response to anakinra in new-onset refractory status epilepticus: A clinical case”
    Author: Massot-TarrĆŗs, A.
    Journal: Seizure
    Year: 2022
    Volume: 94, pp. 92ā€“94
  • šŸ¦  “Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic”
    Co-author: Massot-TarrĆŗs, A.
    Journal: European Journal of Neurology
    Year: 2021
    Volume: 28(10), pp. 3339ā€“3347
  • šŸ“‰ “Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit”
    Author: Massot-TarrĆŗs, A.
    Journal: Epilepsy and Behavior
    Year: 2021
    Volume: 120, 108004
  • šŸ§¬ “E200K familial Creutzfeldt-Jakob disease. MRI, EEG, PET and neuropathological correlation in a family”
    Co-author: Massot-TarrĆŗs, A.
    Journal: Neurologia
    Year: 2021
    Volume: 36(5), pp. 399ā€“401

 

Dr Roberta Gasparro | Neuroscience | Best Paper Award

Posted on by sciencefather

Dr Roberta Gasparro | Neuroscience | Best Paper Award šŸ†

Research Fellow at University of Naples Federico II , ItalyšŸŽ“

Dr. Roberta Gasparro, born in 1988, is a distinguished professional in the field of Dentistry and Oral Surgery. She is a resident of Laureana Cilento, Salerno, Italy. Dr. Gasparro has established herself as a highly qualified dentist and researcher, recognized for her significant contributions to clinical and experimental medicine.

Professional ProfileĀ 

EducationšŸŽ“

Dr. Gasparro began her academic journey with a Scientific High School Diploma in 2007, achieving top marks. She then pursued Biotechnology Sciences at the University of Naples Federico II, later transitioning to Dentistry and Dental Prosthetics. She graduated in 2013 with the highest honors, receiving special mention and publication dignity. In 2017, she earned a PhD in “Clinical and Experimental Medicine” from the same university. Her education was further enhanced by an Advanced Training Course in Oral and Reconstructive Surgery in 2023.

Ā šŸ’¼Work Experience

Dr. Gasparro has held various prestigious positions throughout her career. After obtaining her degree, she worked as a Research Fellow at the University of Naples Federico II in the Department of Neurosciences, Reproductive, and Odontostomatological Sciences. In 2019, she was ranked first in the competition for the Specialization in Oral Surgery. Currently, she serves as a Contract Professor at the University of Salerno, where she teaches Odontostomatological Clinic modules in the Integrated Therapy courses.

Ā šŸ› ļøSkills

Dr. Gasparro’s skills include expertise in Oral Surgery, Implantology, and Maxillofacial Pathology and Therapy. Her academic background and practical experience have equipped her with advanced knowledge in clinical and experimental dentistry, as well as a deep understanding of complex surgical procedures.

Ā šŸ†Awards and Honors

Dr. Gasparro’s excellence has been recognized with several awards, particularly for her oral presentations and poster contributions at national and international conferences. Her work has earned her multiple honors, including being a recipient of special mention for her degree and PhD achievements.

Ā Membership šŸ›ļøand Affiliations šŸ¤

As an active member of various national and international scientific societies, Dr. Gasparro holds several responsibilities, contributing to the advancement of dental and medical sciences. Her involvement in these organizations reflects her commitment to staying at the forefront of her field.

Ā Teaching ExperiencešŸ‘Øā€šŸ«

Dr. Gasparro has extensive teaching experience, having served as a Contract Professor at the University of Salerno since 2020. She has taught the Odontostomatological Clinic module in both Integrated Therapy I and II courses for the Masterā€™s Degree in Dentistry and Dental Prosthetics. Her teaching has been highly regarded, and she continues to contribute to the education of future dental professionals.

Ā Research Focus šŸ”¬

Dr. Gasparro’s research is focused on clinical and experimental medicine, with a particular emphasis on Oral Surgery, Implantology, and Maxillofacial Pathology. She has authored 53 publications in indexed and impact-factor journals, with an H index of 13 and a total of 536 citations, underscoring the impact of her research. Her work has been published in high-ranking journals, including 13 Q1 articles, one of which is in the top decile.

šŸ“–Publications :Ā 

  • The role of cognitive and nonā€cognitive factors in dental anxiety: A mediation model
    šŸ—“ļø 2021
    šŸ“˜ European Journal of Oral Sciences
    āœļø Authors: C. Scandurra, R. Gasparro, P. Dolce, V. Bochicchio, B. Muzii, G. Sammartino, …

 

  • Treatment of periodontal pockets at the distal aspect of mandibular second molar after surgical removal of impacted third molar and application of L-PRF: A split-mouth study
    šŸ—“ļø 2020
    šŸ“˜ Quintessence International
    āœļø Authors: R. Gasparro, G. Sammartino, M. Mariniello, A. Espedito di Lauro, …

 

  • Rhein: A novel antibacterial compound against Streptococcus mutans infection
    šŸ—“ļø 2022
    šŸ“˜ Microbiological Research
    āœļø Authors: V. Folliero, F. Dellā€™Annunziata, E. Roscetto, A. Amato, R. Gasparro, …

 

  • Multidisciplinary approach to fused maxillary central incisors: A case report
    šŸ—“ļø 2014
    šŸ“˜ Journal of Medical Case Reports
    āœļø Authors: G. Sammartino, V. Cerone, R. Gasparro, F. Riccitiello, O. Trosino

 

  • Use of injectable plateletā€rich fibrin in the treatment of plasma cell mucositis of the oral cavity refractory to corticosteroid therapy: A case report
    šŸ—“ļø 2019
    šŸ“˜ Dermatologic Therapy
    āœļø Authors: R. Gasparro, D. Adamo, M. Masucci, G. Sammartino, M.D. Mignogna

 

  • Three-dimensional cell cultures: The bridge between in vitro and in vivo models
    šŸ—“ļø 2023
    šŸ“˜ International Journal of Molecular Sciences
    āœļø Authors: O. UrzƬ, R. Gasparro, E. Costanzo, A. De Luca, G. Giavaresi, S. Fontana, …

 

  • Burning fog: Cognitive impairment in burning mouth syndrome
    šŸ—“ļø 2021
    šŸ“˜ Frontiers in Aging Neuroscience
    āœļø Authors: F. Canfora, E. Calabria, R. Cuocolo, L. Ugga, G. Buono, G. Marenzi, …

 

  • Peri-implant soft tissue management: Cairo opinion consensus conference
    šŸ—“ļø 2020
    šŸ“˜ International Journal of Environmental Research and Public Health
    āœļø Authors: F.S.L. Del Amo, S.H. Yu, G. Sammartino, A. Sculean, G. Zucchelli, G. Rasperini, …

 

  • Effectiveness of surgical procedures in the acceleration of orthodontic tooth movement: Findings from systematic reviews and metaā€analyses
    šŸ—“ļø 2022
    šŸ“˜ Japanese Dental Science Review
    āœļø Authors: R. Gasparro, R. Bucci, F. De Rosa, G. Sammartino, P. Bucci, V. Dā€™AntĆ², …

 

  • The use of piezosurgery in genioplasty
    šŸ—“ļø 2016
    šŸ“˜ Journal of Craniofacial Surgery
    āœļø Authors: R. Rullo, V.M. Festa, F. Rullo, O. Trosino, V. Cerone, R. Gasparro, L. Laino, …

 

  • Plateletā€rich plasma counteracts detrimental effect of highā€glucose concentrations on mesenchymal stem cells from Bichat fat pad
    šŸ—“ļø 2020
    šŸ“˜ Journal of Tissue Engineering and Regenerative Medicine
    āœļø Authors: V. D’Esposito, M. Lecce, G. Marenzi, S. Cabaro, M.R. Ambrosio, …

 

  • Clinical relevance of bone density values from CT related to dental implant stability: A retrospective study
    šŸ—“ļø 2018
    šŸ“˜ BioMed Research International
    āœļø Authors: V. Bruno, C. Berti, C. Barausse, M. Badino, R. Gasparro, D.R. Ippolito, …

 

  • Four-year post-loading results of full-arch rehabilitation with immediate placement and immediate loading implants: A retrospective controlled study
    šŸ—“ļø 2017
    šŸ“˜ Quintessence International
    āœļø Authors: A. Simonpieri, R. Gasparro, G. Pantaleo, J. Mignogna, F. Riccitiello, …